"As a pioneer in using healthcare IT to drive improvements in patient care and safety, we are excited to join NEPSI and to support its efforts to expand the use of ePrescribing," said Surya N. Mohapatra, Ph.D., Chairman and Chief Executive Officer, Quest Diagnostics. "Our company leads the diagnostics industry in driving quality and access to healthcare, and we believe we can accelerate the adoption of e-prescribing by making the combination of lab orders and results in our Care360 Physician Portal product available more broadly for the benefit of physicians and their patients."
NEPSI is a coalition of the nation's leading healthcare and technology companies who share a commitment to improve patient safety by providing free access to simple, safe and secure electronic prescribing for every physician in America. Along with Quest Diagnostics, NEPSI sponsors include national co-sponsors Allscripts and Dell; healthcare sponsors Aetna, Horizon BCBS of New Jersey, NaviMedix and WellPoint; technology sponsors Cisco, Fujitsu, Microsoft, and Sprint; information sponsor Wolters Kluwer Health; connectivity sponsors eRx Networks and SureScripts; and search sponsor Google.
"We are pleased that Quest Diagnostics has joined the growing list of
healthcare and technology companies who are committed to improving patient
safety by sponsoring NEPSI," said Glen Tullman, NEPSI Co-Chair and Chief
Executive Officer of Allscripts. "Further, the lab functionality added by
Quest Diagnostics will extend the reach of eRx NOW to a broader audience of
providers moving them furt
|SOURCE Quest Diagnostics Incorporated|
Copyright©2007 PR Newswire.
All rights reserved